lifestyle.pluralist.com

Boehringer’s HERNEXEOS® approved in China as first oral targeted therapy for previously treated patients with HER2-mutant advanced NSCLC

Written by

Boehringer’s HERNEXEOS® approved in China as first oral targeted therapy for previously treated patients with HER2-mutant advanced NSCLC – NEWSnet – News… as it used to be

More Press Releases

April 22, 2026

Cascade Environmental Releases 2025 Sustainability Report Showcasing Operational Progress and Priorities

April 22, 2026

Goodword Introduces ‘Relationship Intelligence’ as Professionals Rethink Networking in the AI Era

April 22, 2026

Precise Chiropractic Highlights Whole-Body Recovery as Demand for Injury Care Rises in Maryland

April 22, 2026

Urban Fresh Elevates Carpet Cleaning in Singapore with Specialist Expertise